HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Industry Roundup: Warning Letters, DXM Bill, Nutrition Label Update

This article was originally published in The Tan Sheet

Executive Summary

DXM age-restriction bill in Senate; Mosquito band marketer settles with FTC; and more news in brief.

You may also be interested in...



'Step-By-Step' Label Guidance On Converting Nutrients' Units Of Measure

FDA provides "step-by-step instructions on how to convert" units of measure for folate, niacin and vitamins A, D and E to units required in the agency's 2016 final rule for Supplement and Nutrition Facts labels. Compliance date for firms with sales of $10m and up.

Mosquito Repellent Promotion Tumbles On Undisclosed Paid Social Media Plugs By US Olympic Gymnasts

FTC proposes settlements with marketing and public relations firm Creaxion and Inside Publications over regulatory violations in advertising for Fit Organic Mosquito Repellent including failing to disclose US Olympic gymnasts as paid social medial endorsers and misrepresenting that paid commercial ads are opinions from an independent or objective publishers or sources.

States’ Limits On OTC Dextromethorphan Sales Could Force Congress’ Hand

US House legislation banning the sale of DXM OTCs to consumers under age 18 likely stands the same chance right now as previous versions that have failed, but CHPA expects an increasing number of state laws could spur future action.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS141439

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel